tirzepatide fda news Announces End of Shortage: What This Means for Medspas and Compounders New FDA Pick Could Save

Prescription rates surged 111% in 2023 as patients demanded the weight loss drug for off-label use without understanding the serious side effects

If stool is hard despite fiber and fluids, consider osmotic laxatives or stool softeners after checking with your clinician

However, this time, no one took out their phones

According to the Evaluate consultancys 2026 Preview report, Mounjaro and Zepbound are projected to collectively generate more than $45 billion in global sales in 2026, overtaking Mercks Keytruda to become the worlds best-selling drug

There were also noted improvements in markers of glycemic control and insulin sensitivity